Author

U. Khalid

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:rat· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

I. Grigorieva· 2 shared R. Chavez· 2 shared R. Steadman· 2 shared S. Meran· 2 shared A. Ernst· 1 shared A. Midgley· 1 shared A. Plaas· 1 shared A. Williams· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

I. Grigorieva

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The Hyaluronan Synthase isoforms direct distinct patterns of fibroblast activation linked to fibrosis progression versus resolution following renal ischaemia

I. Grigorieva, A. Midgley, C. Brown, G. Chavez, A. Williams, D. Manetta-Jones, T. Bowen, D. Chan, A. Plaas, R. Chavez, R. Steadman, U. Khalid, S. Meran

This study compares HA and HAS enzyme expression in kidney development, health, disease, and recovery, identifying distinct roles of HAS1 and HAS2 in fibroblast activation linked to fibrosis progression versus resolution.

bioRxiv · Mar 27, 2024Pathology

Ischaemic Preconditioning attenuates Chronic Renal Damage following Ischaemia Reperfusion Injury

C. V. M. Brown, G. Pino-Chavez, A. Zaidi, I. Grigorieva, E. Woods, R. Steadman, R. Chavez, S. Meran, U. Khalid

This study shows that ischaemic preconditioning reduces chronic renal damage and fibrosis following ischaemia reperfusion injury in a rat model.

bioRxiv · Jul 13, 2023 · PreprintPathology

A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis

U. Khalid, M. Simovic, M. Iskar, J. K. L. Wong, R. Kumar, M. Jugold, M. Sill, M. Bolkestein, T. Kolb, M. Hergt, F. Devens, J. Ecker, M. Kool, T. Milde, F. Westermann, , A. Ernst

The paper identifies a synergistic effect between HDAC and PARP inhibitors in childhood tumors with chromothripsis, validated through drug screening and in vivo models.

bioRxiv · Apr 22, 2021Cancer Biology